Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats - PubMed (original) (raw)
. 2001 Sep 15;65(6):549-64.
doi: 10.1002/jnr.1185.
Affiliations
- PMID: 11550223
- DOI: 10.1002/jnr.1185
Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats
B T Himes et al. J Neurosci Res. 2001.
Abstract
To test the idea that genetically engineered cells can rescue axotomized neurons, we transplanted fibroblasts and immortalized neural stem cells (NSCs) modified to express neurotrophic factors into the injured spinal cord. The neurotrophin-3 (NT-3) or nerve growth factor (NGF) transgene was introduced into these cells using recombinant retroviral vectors containing an internal ribosome entry site (IRES) sequence and the beta-galactosidase or alkaline phosphatase reporter gene. Bioassay confirmed biological activity of the secreted neurotrophic factors. Clarke's nucleus (CN) axons, which project to the rostral spinal cord and cerebellum, were cut unilaterally in adult rats by T8 hemisection. Rats received transplants of fibroblasts or NSCs genetically modified to express NT-3 or NGF and a reporter gene, only a reporter gene, or no transplant. Two months postoperatively, grafted cells survived at the hemisection site. Grafted fibroblasts and NSCs expressed a reporter gene and immunoreactivity for the NGF or NT-3 transgene. Rats receiving no transplant or a transplant expressing only a reporter gene showed a 30% loss of CN neurons in the L1 segment on the lesioned side. NGF-expressing transplants produced partial rescue compared with hemisection alone. There was no significant neuron loss in rats receiving grafts of either fibroblasts or NSCs engineered to express NT-3. We postulate that NT-3 mediates survival of CN neurons through interaction with trkC receptors, which are expressed on CN neurons. These results support the idea that NT-3 contributes to long-term survival of axotomized CN neurons and show that genetically modified cells rescue axotomized neurons as efficiently as fetal CNS transplants.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
- Grafts of fetal central nervous system tissue rescue axotomized Clarke's nucleus neurons in adult and neonatal operates.
Himes BT, Goldberger ME, Tessler A. Himes BT, et al. J Comp Neurol. 1994 Jan 1;339(1):117-31. doi: 10.1002/cne.903390111. J Comp Neurol. 1994. PMID: 8106656 - Neurotrophin-3 prevents death of axotomized Clarke's nucleus neurons in adult rat.
Shibayama M, Hattori S, Himes BT, Murray M, Tessler A. Shibayama M, et al. J Comp Neurol. 1998 Jan 5;390(1):102-11. J Comp Neurol. 1998. PMID: 9456179 - Transplantation of genetically modified cells contributes to repair and recovery from spinal injury.
Murray M, Kim D, Liu Y, Tobias C, Tessler A, Fischer I. Murray M, et al. Brain Res Brain Res Rev. 2002 Oct;40(1-3):292-300. doi: 10.1016/s0165-0173(02)00211-4. Brain Res Brain Res Rev. 2002. PMID: 12589927 Review. - Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair.
Blesch A, Lu P, Tuszynski MH. Blesch A, et al. Brain Res Bull. 2002 Apr;57(6):833-8. doi: 10.1016/s0361-9230(01)00774-2. Brain Res Bull. 2002. PMID: 12031281 Review.
Cited by
- Effects of human mesenchymal stem cell transplantation combined with polymer on functional recovery following spinal cord hemisection in rats.
Choi JS, Leem JW, Lee KH, Kim SS, Suh-Kim H, Jung SJ, Kim UJ, Lee BH. Choi JS, et al. Korean J Physiol Pharmacol. 2012 Dec;16(6):405-11. doi: 10.4196/kjpp.2012.16.6.405. Epub 2012 Dec 10. Korean J Physiol Pharmacol. 2012. PMID: 23269903 Free PMC article. - [Therapeutic use of stem cells].
Knipper M. Knipper M. HNO. 2007 Nov;55(11):845-7. doi: 10.1007/s00106-007-1626-5. HNO. 2007. PMID: 17943260 Review. German. No abstract available. - A pilot study of poly(N-isopropylacrylamide)-g-polyethylene glycol and poly(N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cord.
Conova L, Vernengo J, Jin Y, Himes BT, Neuhuber B, Fischer I, Lowman A, Vernengo J, Jin Y, Himes BT, Neuhuber B, Fischer I, Lowman A. Conova L, et al. J Neurosurg Spine. 2011 Dec;15(6):594-604. doi: 10.3171/2011.7.SPINE11194. Epub 2011 Sep 2. J Neurosurg Spine. 2011. PMID: 21888482 Free PMC article. - Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.
Franz S, Weidner N, Blesch A. Franz S, et al. Exp Neurol. 2012 May;235(1):62-9. doi: 10.1016/j.expneurol.2011.01.015. Epub 2011 Jan 31. Exp Neurol. 2012. PMID: 21281633 Free PMC article. Review. - Neural stem cells injected into the sound-damaged cochlea migrate throughout the cochlea and express markers of hair cells, supporting cells, and spiral ganglion cells.
Parker MA, Corliss DA, Gray B, Anderson JK, Bobbin RP, Snyder EY, Cotanche DA. Parker MA, et al. Hear Res. 2007 Oct;232(1-2):29-43. doi: 10.1016/j.heares.2007.06.007. Epub 2007 Jun 20. Hear Res. 2007. PMID: 17659854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials